A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs is a phase 1/2 interventional study registered as NCT07336446 by AstraZeneca, with 300 participants planned, started 2026-01-27 and due to reach its primary completion in 2029-01-26. Interventions recorded: AZD9750, AZD5305. Conditions listed: Prostate Cancer. No results are recorded here; the registry entry is the source.